Sucampo Pharmaceuticals, Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - August 5, 2015

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc.exh_322.htm
EX-10.1 - EXHIBIT 10.1 - Sucampo Pharmaceuticals, Inc.exh_101.htm
EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc.exh_311.htm
EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc.exh_321.htm
EX-10.3 - EXHIBIT 10.3 - Sucampo Pharmaceuticals, Inc.exh_103.htm
10-Q - FORM 10-Q - Sucampo Pharmaceuticals, Inc.gff10q_080515.htm
EX-10.2 - EXHIBIT 10.2 - Sucampo Pharmaceuticals, Inc.exh_102.htm
EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc.exh_312.htm
v3.2.0.727
Label Element Value
Non Employee Stock Plan 2001 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 5.85
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 255,000
Stock Incentive Plan 2006 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 6.93
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 4,021,491
Two Thousand One Incentive Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 10.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 113,900

Sucampo Pharmaceuticals, Inc. Reports